Bone cell-independent benefits of raloxifene on the skeleton: A novel mechanism for improving bone material properties

Raloxifene is an FDA approved agent used to treat bone loss and decrease fracture risk. In clinical trials and animal studies, raloxifene reduces fracture risk and improves bone mechanical properties, but the mechanisms of action remain unclear because these benefits occur largely independent of cha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gallant, Maxime A., Brown, Drew M., Hammond, Max, Wallace, Joseph M., Du, Jiang, Deymier-Black, Alix C., Almer, Jonathan D., Stock, Stuart R., Allen, Matthew R., Burr, David B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3955028/
https://ncbi.nlm.nih.gov/pubmed/24468719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2014.01.009
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge